NEWS | alsv | Page 8 of 18

Companies in the News

Oct 14, 2020

Pacemaker Pair Keeps Monique in Sync -- EBR Systems

A pair of revolutionary leadless pacemakers have been successfully implanted into the heart of a patient in Melbourne in a world-first...

Oct 6, 2020

Federation Bio goes live with $50M to pursue microbial treatments

Several companies are exploring microbiome treatments for various ailments, ranging from Parkinson’s disease and multiple sclerosis to...

Sep 23, 2020

Nutcracker Therapeutics Announces $60 Million Series B Financing

Emeryville, Calif. – September 23, 2020 Financing led by ARCH Venture Partners Company aims to efficiently develop, manufacture and...

Sep 14, 2020

Escient Pharmaceuticals Raises $77.5 Million Series B Round and Initiates a Phase 1/1b Clinical Tria

Proceeds support clinical development for lead program in cholestatic and uremic pruritus and second program for mast cell-related...

Aug 4, 2020

Indigo Ag announces an additional $360M in financing, appoints Stéphane Bancel, Moderna CEO, to Boar

Indigo Ag announces an additional $360M in financing, appoints Stéphane Bancel, Moderna CEO, to Board of Directors Indigo announces an...

Jul 27, 2020

Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in S

Financing led by GV with participation from Matrix Capital Management, ARCH Venture Partners, Illumina Ventures, RTW Investments, Boxer...

Jun 23, 2020

Sana Biotechnology Announces Completion of Initial Financing

SEATTLE — Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all...

Jun 17, 2020

Indigo Places #3 on CNBC’s Disruptor 50 2020 List

Founders: David Perry, Geoffrey von Maltzahn and Noubar Afeyan CEO: David Perry Launched: 2014 Headquarters: Boston Funding: $850 million...

Jun 15, 2020

Magenta Enters Collaboration Agreement with Beam to Further Explore MGTA-117

Cambridge-based Magenta Therapeutics announced today that it has entered a non-exclusive research and clinical collaboration agreement...